IMI1 – Call 1
IMI1 – Call 1 was launched on 30 April 2008 with the following topics:
- Improve predictivity of immunogenicity
- Non-genotoxic carcinogenesis
- Expert systems for in silico toxicity prediction
- Improved predictivity of non-clinical safety evaluation
- Qualification of translational safety biomarkers
- Strengthening the monitoring of benefit/risk
- Islet cell research
- Surrogate markers for vascular endpoints
- Pain research
- New tools for the development of novel therapies in psychiatric disorders
- Neurodegenerative disorders
- Understanding severe asthma
- COPD patient reported outcomes
- European medicines research training network
- Safety sciences for medicines training programme
- Pharmaceutical medicine training programme
- Integrated medicines development programme
- Pharmacovigilance training programme
More information on the topics can be found in IMI’s press release and in the Call text. Other relevant documents, including documents for applicants, the list of expert reviewers, and the independent observers’ reports of the evaluations, can be found on the IMI1 Call documents page
Projects
The projects resulting from IMI1 – Call 1 are:
- EMTRAIN - European medicines research training network
factsheet | website - eTOX - Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities
factsheet | website - Eu2P - European programme in pharmacovigilance and pharmacoepidemiology
factsheet | website - EUROPAIN - Understanding chronic pain and improving its treatment
factsheet | website - IMIDIA - Improving beta-cell function and identification of diagnostic biomarkers for treatment monitoring in diabetes
factsheet | website - MARCAR - Biomarkers and molecular tumour classification for non-genotoxic carcinogenesis
factsheet | website - NEWMEDS - Novel methods leading to new medications in depression and schizophrenia
factsheet | website - Pharma-Cog - Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development
factsheet | website - Pharmatrain - Pharmaceutical medicine training programme
factsheet | website - PRO-active - Physical activity as a crucial patient reported outcome in COPD
factsheet - PROTECT - Pharmacoepidemiological research on outcomes of therapeutics by a European consortium
factsheet | website - SAFE-T - Safer and faster evidence-based translation
factsheet | website - SafeSciMET - European modular education and training programme in safety sciences for medicines
factsheet | website - SUMMIT - Surrogate markers for micro- and macro-vascular hard endpoints for innovative diabetes tools
factsheet | website - U-BIOPRED - Unbiased biomarkers for the prediction of respiratory disease outcomes
factsheet | website